Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0645

+0.8%

10:26 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: boomertree2	1/16/2014 9:32:04 AM
	of 13111

Good timing for pv-10. Bristol-Myers Plans Acquisitions Of New Medications, Especially For Cancer. Bloomberg News (1/15, Armstrong) reports Bristol-Myers Squibb Co. will “continue to seek out innovative drugs to buy, particularly for cancer,” despite “two previous deals totaling $7.8 billion in the last three years that failed to pay off for them.” The pharmaceutical firm will “target experimental treatments still in development, rather than commercial products that are already on the market,” according to Chief Financial Officer Charles Bancroft. In November, the company said it was ending research “in diabetes, hepatitis C and neuroscience to put more resources into cancer.”

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next